Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) FCF Margin: 2010-2021

Historic FCF Margin for Neurocrine Biosciences (NBIX) over the last 8 years, with Sep 2021 value amounting to 18.95%.

  • Neurocrine Biosciences' FCF Margin rose 2700.00% to 18.95% in Q3 2021 from the same period last year, while for Sep 2021 it was 30.65%, marking a year-over-year increase of 932.00%. This contributed to the annual value of 20.81% for FY2020, which is 402.00% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported FCF Margin of 18.95% as of Q3 2021, which was down 44.64% from 34.23% recorded in Q2 2021.
  • Over the past 5 years, Neurocrine Biosciences' FCF Margin peaked at 42.46% during Q3 2019, and registered a low of -767.73% during Q2 2017.
  • In the last 3 years, Neurocrine Biosciences' FCF Margin had a median value of 34.23% in 2021 and averaged 18.03%.
  • Per our database at Business Quant, Neurocrine Biosciences' FCF Margin soared by 78,408bps in 2018 and then tumbled by 5,050bps in 2020.
  • Neurocrine Biosciences' FCF Margin (Quarterly) stood at 40.41% in 2017, then tumbled by 658bps to 33.84% in 2018, then skyrocketed by 496bps to 38.80% in 2019, then plummeted by 249bps to 36.30% in 2020, then spiked by 2,700bps to 18.95% in 2021.
  • Its FCF Margin was 18.95% in Q3 2021, compared to 34.23% in Q2 2021 and 35.00% in Q1 2021.